Coronavirus

Flu cases surge in the UK hospitals while China battles human metapneumovirus

Flu Season: New data from the NHS shows rapid rise in flu cases across the UK, whilst across the world, china continues its battle against human metapneumovirus virus.

Pfizer vaccine produces greater antibody response when given at 12 weeks

A new study has found that the second dose of the Pfizer vaccine produces a 3.5-times greater antibody response when given at 12 weeks, compared to three weeks.

Scientists investigate link between endothelium and Long COVID

Scientists examining how COVID impacts the entire human body, not just the lungs, believe that there could be a link between the endothelium and Long COVID.

COVID-19 can trigger repeating blood clots in arm

A team at Rutgers Robert Wood Johnson Medical School have found evidence of rare, repeating blood clots in the arms of COVID-19 patients.

Global bioinformatics surveillance: SARS-CoV-2 variant detection tests

Shiao Yee, Marketing Communications Manager, Novacyt Group, discusses how global bioinformatics surveillance drives innovation in SARS-CoV-2 variant detection tests.

Study says 66% of Indian public blame Muslim population for COVID

Researchers at Monash Business School surveyed the Indian public in Uttar Pradesh, finding that 66% blame the Muslim population for the spread of COVID.

Pfizer vaccine can be given to 12-15 year olds in US

On Wednesday (12 May), the CDC announced that the Pfizer vaccine could now be given to 12-15 year olds - effective immediately for 17 million adolescents.

What lasting legacies of COVID-19 will local government take forward?

Lorraine Smith, Divisional Managing Director at Civica, discusses how the pandemic has not only re-shaped local government when it comes to new ways of working but also in transforming citizen engagement.

Clean energy technology demand will quadruple need for critical minerals

Supplies of critical minerals essential for key clean energy technologies like electric vehicles and wind turbines, will need to increase significantly over the coming decades to meet the world’s climate goals.

Options for struggling businesses in the aftermath of COVID-19

John Bell, director and founder of Clarke Bell, ponders the impact of COVID-19 on the economy and what options struggling businesses could be facing in the coming months and years ahead.

Study examines immune responses to COVID in patients with antibody deficiencies

A new study aims to explore the immune response to COVID-19 infection and vaccination in patients with antibody deficiencies.

Why COVID vaccine development was exceptionally speedy

Ram May-Ron, Managing Partner at FreeMind Group, explains why COVID vaccine development was exceptionally speedy.

COVID-19 vaccine does not damage placentas

Researchers from Northwestern Medicine have studied the placentas from patients who received the COVID-19 vaccine during pregnancy and found no evidence of damage.

HIV patients are more likely to die from COVID-19

In a new study, researchers have found that individuals living with HIV and AIDS have an increased risk of death from COVID-19 infection.

Immune system research: Vaccines and immunotherapeutics

Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.

The connection between art and mental health during lockdown

Here, Deirdre Figueiredo, MBE and Director of Craftspace, discusses the relationship between art, community and mental health during lockdown.

Nepal faces 1200% increase in COVID cases

Nepal, which shares a long border with hard-hit India, is experiencing a meteoric rise in COVID-19 cases and facing an oxygen shortage.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders